tuberculosis
M42 study highlights positive performance of AI model for tuberculosis screening
August 6, 2025Research and Development AI, Infections and infestations, M42, X-ray, tuberculosis
Healthcare tech company, M42, has published results from one of the largest real-world studies of an artificial intelligence (AI)-powered tuberculosis …
GSK’s tuberculosis vaccine shows efficacy over three years in HIV negative patients
October 29, 2019Manufacturing and Production, Research and Development GSK, IAVI, Vaccine, pharma, tuberculosis
Promising results have been revealed from a GlaxoSmithKline study, conducted in partnership with non-profit scientific research organisation IAVI, investigating the …
FDA approve new drug for treatment-resistant TB
August 15, 2019Research and Development FDA, TB, US, pharma, pretomanid, tuberculosis
The US FDA has approved BPaL, the TB Alliance’s treatment for drug-resistant tuberculosis (TB). The US regulator gave the go-ahead …
New diagnostic tool predicts tuberculosis infection with 73% accuracy
July 10, 2019Research and Development diagnosis, pharma, tuberculosis
A new diagnostic technology has demonstrated the ability to identify human tuberculosis (TB) infection and those at highest risk of …
FDA advisory panel backs TB Alliance’s tuberculosis regimen
June 10, 2019Sales and Marketing FDA, TB Alliance, US, pharma, tuberculosis
An FDA advisory panel has voted to recommend the investigational drug pretomanid, developed by the non-profit organisation TB Alliance, as …
Global Fund seeks £11bn as progress slows in fight against malaria, TB and HIV
January 14, 2019Sales and Marketing Africa, Global Fund, HIV, TB, infectious diseases, malaria, tuberculosis
The Global Fund is seeking £11 billion worth of investment in an attempt to save 16 million lives in the …
J&J pledges to end global TB pandemic
September 25, 2018Manufacturing and Production J&J, JJ, Johnson and Johnson, TB, access, tuberculosis
Johnson and Johnson have announced that they are launching a 10-year initiative aimed at helping to end tuberculosis, the world’s …
Eisai forms partnership to find new tuberculosis treatment
April 13, 2018Medical Communications, Research and Development Colorado State University, Eisai, broad institute, pharma, tuberculosis, university of chicago
Eisai has teamed up with the Broad Institute, the Mycobacteria Research Laboratories at Colorado State University and the University of …
Body’s natural defence mechanism against TB discovered
May 11, 2017Research and Development Francis Crick Institute, TB, tuberculosis
Research conducted by the Francis Crick Institute has revealed how the body protects itself from Mycobacterium tuberculosis, the bacterium responsible …
Treatment combating multi-drug resistant TB posts positive results
March 27, 2017Research and Development, Sales and Marketing Infectex, Sequella, tuberculosis
Infectex, a Russian portfolio company of Maxwell Biotech Venture Fund, announced that it had found positive results from its latest …
Bayer to collaborate on new treatments for tuberculosis with Universities of Dundee, Cape Town
March 8, 2016Manufacturing and Production, Research and Development Bayer, TB, tuberculosis, university of cape town, university of dundee
The pharmaceuticals division at German-based Bayer will collaborate with the renowned medicinal chemistry and biology departments at the Universities of …
Janssen in new collaboration to take on TB
December 3, 2015Research and Development FIND, Janssen, antibiotic resistance, tuberculosis
Janssen has announced a new collaboration with the non-profit organisation FIND to step-up the fight against the public health threat …
Medicines Patent Pool to include hep C and TB drugs
November 9, 2015Sales and Marketing Medicines Patent Pool, affordable drugs, hep C, hepatitis, hepatitis C, medicines access, tuberculosis
The Medicines Patent Pool has expanded to include a mandate to make treatments for hepatitis C and tuberculosis affordable and …
MSF hits out at ‘astronomical’ vaccine prices
January 20, 2015Research and Development, Sales and Marketing Doctors Without Borders, GSK, Médicines San Frontières, Pfizer, Vaccine, diphtheria, measles, pertussis, poliomyelitis, tetanus, tuberculosis
Pharma companies have been named and shamed in a report calling on manufacturers to lower the cost of childhood vaccines …
Europe: TB treatment ‘far below’ target
March 19, 2014Research and Development, Sales and Marketing EU, MDR TB, TB, WHO, tuberculosis
European countries are still not getting to grips with the diagnosis and treatment of tuberculosis, according to a new report …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
